BRASKEM SA-CLASS A- ADR (BAK) Fundamental Analysis & Valuation

NYSE:BAK • US1055321053

Current stock price

3.78 USD
+0.16 (+4.42%)
At close:
3.7983 USD
+0.02 (+0.48%)
After Hours:

This BAK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BAK Profitability Analysis

1.1 Basic Checks

  • BAK had negative earnings in the past year.
  • In the past year BAK has reported a negative cash flow from operations.
  • In the past 5 years BAK reported 4 times negative net income.
  • In multiple years BAK reported negative operating cash flow during the last 5 years.
BAK Yearly Net Income VS EBIT VS OCF VS FCFBAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.36%, BAK is doing worse than 74.39% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 0.56%, BAK is doing worse than 71.95% of the companies in the same industry.
Industry RankSector Rank
ROA -6.36%
ROE N/A
ROIC 0.56%
ROA(3y)-5.51%
ROA(5y)-1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BAK Yearly ROA, ROE, ROICBAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

  • BAK's Operating Margin of 0.60% is on the low side compared to the rest of the industry. BAK is outperformed by 75.61% of its industry peers.
  • In the last couple of years the Operating Margin of BAK has declined.
  • BAK has a Gross Margin of 6.52%. This is amonst the worse of the industry: BAK underperforms 89.02% of its industry peers.
  • BAK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.6%
PM (TTM) N/A
GM 6.52%
OM growth 3Y-60.34%
OM growth 5Y-26.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.57%
GM growth 5Y-9.41%
BAK Yearly Profit, Operating, Gross MarginsBAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BAK Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BAK is destroying value.
  • BAK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BAK Yearly Shares OutstandingBAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BAK Yearly Total Debt VS Total AssetsBAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 0.78, we must say that BAK is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.78, BAK is doing worse than 81.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACC0.1
WACC5.62%
BAK Yearly LT Debt VS Equity VS FCFBAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

  • BAK has a Current Ratio of 1.21. This is a normal value and indicates that BAK is financially healthy and should not expect problems in meeting its short term obligations.
  • BAK has a worse Current ratio (1.21) than 85.37% of its industry peers.
  • A Quick Ratio of 0.68 indicates that BAK may have some problems paying its short term obligations.
  • The Quick ratio of BAK (0.68) is worse than 85.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.68
BAK Yearly Current Assets VS Current LiabilitesBAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BAK Growth Analysis

3.1 Past

  • BAK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.75%, which is quite good.
EPS 1Y (TTM)12.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.93%

3.2 Future

  • BAK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.35% yearly.
  • Based on estimates for the next years, BAK will show a quite strong growth in Revenue. The Revenue will grow by 8.02% on average per year.
EPS Next Y67.37%
EPS Next 2Y38.35%
EPS Next 3Y23.35%
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y8.05%
Revenue Next 3Y8.02%
Revenue Next 5YN/A

3.3 Evolution

BAK Yearly Revenue VS EstimatesBAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B 100B
BAK Yearly EPS VS EstimatesBAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 20 -20 40

More info and screens

Find the best growth stocksShow best growing peers

1

4. BAK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BAK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BAK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BAK Price Earnings VS Forward Price EarningsBAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BAK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.51
BAK Per share dataBAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • BAK's earnings are expected to grow with 23.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.35%
EPS Next 3Y23.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BAK Dividend Analysis

5.1 Amount

  • BAK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAK Fundamentals: All Metrics, Ratios and Statistics

BRASKEM SA-CLASS A- ADR

NYSE:BAK (4/10/2026, 8:07:14 PM)

After market: 3.7983 +0.02 (+0.48%)

3.78

+0.16 (+4.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-27
Earnings (Next)05-12
Inst Owners18.54%
Inst Owner Change0.05%
Ins Owners0.1%
Ins Owner Change0%
Market Cap1.51B
Revenue(TTM)N/A
Net Income(TTM)-5.81B
Analysts48
Price Target4.4 (16.4%)
Short Float %4.38%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)-61.09%
DP-0.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)77.08%
Min EPS beat(2)64.59%
Max EPS beat(2)89.58%
EPS beat(4)2
Avg EPS beat(4)-292.98%
Min EPS beat(4)-870.87%
Max EPS beat(4)89.58%
EPS beat(8)2
Avg EPS beat(8)-200.87%
EPS beat(12)3
Avg EPS beat(12)-141.89%
EPS beat(16)4
Avg EPS beat(16)-120.57%
Revenue beat(2)0
Avg Revenue beat(2)-9.32%
Min Revenue beat(2)-10.48%
Max Revenue beat(2)-8.16%
Revenue beat(4)0
Avg Revenue beat(4)-6.86%
Min Revenue beat(4)-10.48%
Max Revenue beat(4)-1.01%
Revenue beat(8)0
Avg Revenue beat(8)-4.75%
Revenue beat(12)1
Avg Revenue beat(12)-3.68%
Revenue beat(16)2
Avg Revenue beat(16)-3.02%
PT rev (1m)-5.82%
PT rev (3m)-5.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-17.11%
EPS NY rev (3m)6.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 13.51
EPS(TTM)-4.9
EYN/A
EPS(NY)-1.6
Fwd EYN/A
FCF(TTM)-2.86
FCFYN/A
OCF(TTM)-1.29
OCFYN/A
SpS38.6
BVpS-1.89
TBVpS-3.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.36%
ROE N/A
ROCE 0.71%
ROIC 0.56%
ROICexc 0.56%
ROICexgc 0.59%
OM 0.6%
PM (TTM) N/A
GM 6.52%
FCFM N/A
ROA(3y)-5.51%
ROA(5y)-1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-67.54%
ROICexgc growth 5Y-28.26%
ROICexc growth 3Y-67.47%
ROICexc growth 5Y-28%
OM growth 3Y-60.34%
OM growth 5Y-26.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.57%
GM growth 5Y-9.41%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 11.38
Cap/Depr 65.27%
Cap/Sales 4.08%
Interest Coverage 0.1
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.68
Altman-Z 0.78
F-Score3
WACC5.62%
ROIC/WACC0.1
Cap/Depr(3y)88.47%
Cap/Depr(5y)83.1%
Cap/Sales(3y)5.43%
Cap/Sales(5y)4.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.07%
EPS Next Y67.37%
EPS Next 2Y38.35%
EPS Next 3Y23.35%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.93%
Revenue Next Year9.06%
Revenue Next 2Y8.05%
Revenue Next 3Y8.02%
Revenue Next 5YN/A
EBIT growth 1Y374.38%
EBIT growth 3Y-64.24%
EBIT growth 5Y-20.05%
EBIT Next Year183.3%
EBIT Next 3Y95.81%
EBIT Next 5Y72.54%
FCF growth 1Y-736.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-158.55%
OCF growth 3Y-45.19%
OCF growth 5Y1.46%

BRASKEM SA-CLASS A- ADR / BAK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BRASKEM SA-CLASS A- ADR (BAK) stock?

ChartMill assigns a fundamental rating of 1 / 10 to BAK.


Can you provide the valuation status for BRASKEM SA-CLASS A- ADR?

ChartMill assigns a valuation rating of 1 / 10 to BRASKEM SA-CLASS A- ADR (BAK). This can be considered as Overvalued.


How profitable is BRASKEM SA-CLASS A- ADR (BAK) stock?

BRASKEM SA-CLASS A- ADR (BAK) has a profitability rating of 0 / 10.


Is the dividend of BRASKEM SA-CLASS A- ADR sustainable?

The dividend rating of BRASKEM SA-CLASS A- ADR (BAK) is 0 / 10 and the dividend payout ratio is -0.02%.